Full text is available at the source.
Abstract
The use of incretin-based therapies for weight management has expanded rapidly but presents several challenges.
- Inconsistent prescribing practices are common in real-world applications of incretin-based therapies.
- Access barriers may limit patient utilization of these treatments.
- Limited long-term safety data raises concerns about the ongoing use of these therapies.
- Low treatment persistence is observed among patients using incretin-based therapies.
- Equity and financial sustainability issues are significant considerations in the adoption of these therapies.
Simplified